142 related articles for article (PubMed ID: 34644732)
1. Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC).
Carvalho SCR; Vasconcelos LRS; Fonseca LD; Carmo RF; Tomitão MT; Aroucha DCBL; Pereira LMMB; Stefano JT; Ribeiro-Júnior U; Oliveira CP; Carrilho FJ
Clinics (Sao Paulo); 2021; 76():e2881. PubMed ID: 34644732
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.
Zhang S; Jiang J; Tang W; Liu L
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931
[TBL] [Abstract][Full Text] [Related]
3. Association of MTHFR and TYMS gene polymorphisms with the susceptibility to HCC in Egyptian HCV cirrhotic patients.
Abdel Allah HMM; Zahran WE; El-Masry SA; El-Bendary M; Soliman AF
Clin Exp Med; 2022 May; 22(2):257-267. PubMed ID: 34297238
[TBL] [Abstract][Full Text] [Related]
4. Association between methylenetetrahydrofolate reductase tagging polymorphisms and susceptibility of hepatocellular carcinoma: a case-control study.
Zhang S; Lin J; Jiang J; Chen Y; Tang W; Liu L
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31694048
[TBL] [Abstract][Full Text] [Related]
5. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.
Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S
Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
[TBL] [Abstract][Full Text] [Related]
7. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between
Su H
Nutr Cancer; 2019; 71(7):1055-1060. PubMed ID: 31282757
[TBL] [Abstract][Full Text] [Related]
9. Genetic Polymorphism of MTHFR C677T Influences Susceptibility to HBV-Related Hepatocellular Carcinoma in a Chinese Population: a Case-Control Study.
Qiao K; Zhang S; Trieu C; Dai Q; Huo Z; Du Y; Lu W; Hou W
Clin Lab; 2017 Apr; 63(4):787-795. PubMed ID: 28397480
[TBL] [Abstract][Full Text] [Related]
10. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Methylenetetrahydrofolate Reductase Polymorphisms and Hepatocellular Carcinoma: A Meta-Analysis.
Su H; Zhang G
Ann Nutr Metab; 2019; 74(3):251-256. PubMed ID: 30917367
[TBL] [Abstract][Full Text] [Related]
12. VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.
Scartozzi M; Faloppi L; Svegliati Baroni G; Loretelli C; Piscaglia F; Iavarone M; Toniutto P; Fava G; De Minicis S; Mandolesi A; Bianconi M; Giampieri R; Granito A; Facchetti F; Bitetto D; Marinelli S; Venerandi L; Vavassori S; Gemini S; D'Errico A; Colombo M; Bolondi L; Bearzi I; Benedetti A; Cascinu S
Int J Cancer; 2014 Sep; 135(5):1247-56. PubMed ID: 24510746
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the VEGFA promoter are associated with susceptibility to hepatocellular carcinoma by altering promoter activity.
Wu X; Xin Z; Zhang W; Wu J; Chen K; Wang H; Zhu X; Pan L; Li Z; Li H; Liu Y
Int J Cancer; 2013 Sep; 133(5):1085-93. PubMed ID: 23404364
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population.
Mu LN; Cao W; Zhang ZF; Cai L; Jiang QW; You NC; Goldstein BY; Wei GR; Chen CW; Lu QY; Zhou XF; Ding BG; Chang J; Yu SZ
Cancer Causes Control; 2007 Aug; 18(6):665-75. PubMed ID: 17503006
[TBL] [Abstract][Full Text] [Related]
15. MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study.
Khidri FF; Waryah YM; Ali FK; Shaikh H; Ujjan ID; Waryah AM
BMC Med Genet; 2019 Oct; 20(1):163. PubMed ID: 31646966
[TBL] [Abstract][Full Text] [Related]
16. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF
Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892
[TBL] [Abstract][Full Text] [Related]
17. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
[TBL] [Abstract][Full Text] [Related]
18. The role of vascular endothelial growth factor -634 G/C and its soluble receptor on chronic liver disease and hepatocellular carcinoma.
Ratnasari N; Nurdjanah S; Sadewa AH; Hakimi M
Arab J Gastroenterol; 2016 Jun; 17(2):61-6. PubMed ID: 27426958
[TBL] [Abstract][Full Text] [Related]
19. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
[TBL] [Abstract][Full Text] [Related]
20. Association of genetic variants in the interleukin-18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection.
Bakr NM; Awad A; A Moustafa E
IUBMB Life; 2018 Feb; 70(2):165-174. PubMed ID: 29341496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
